These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19521941)

  • 1. [Position paper of the Working Group of Three Polish National Consultants in internal medicine, gastroenterology and cardiology concerning the rules of gastrointestinal complications' prevention during antiplatelet treatment].
    Imiela J; Opolski G; Rydzewska G; Baczewska-Mazurkiewicz D; Małecki R; Filipiak KJ;
    Kardiol Pol; 2009 May; 67(5):536-8. PubMed ID: 19521941
    [No Abstract]   [Full Text] [Related]  

  • 2. Position paper of the working group of three Polish national consultants in internal medicine, gastroenterology, and cardiology on prevention of gastrointestinal complications during antiplatelet treatment.
    Imiela J; Opolski G; Rydzewska G; Baczewska-Mazurkiewicz D; Małecki R; Filipiak KJ
    Pol Arch Med Wewn; 2009 Jun; 119(6):347-8. PubMed ID: 19694214
    [No Abstract]   [Full Text] [Related]  

  • 3. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
    Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical GI issues for the cardiologist: new insights and understanding. Introduction.
    Faxon DP; Johnson DA
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S1-2. PubMed ID: 17710071
    [No Abstract]   [Full Text] [Related]  

  • 5. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
    Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM;
    Circulation; 2008 Oct; 118(18):1894-909. PubMed ID: 18836135
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastroduodenal mucosal injury in patients on antiplatelet therapy.
    Yamamoto T; Sanaka M; Nagasawa K; Abe K; Fukami M; Nakayama S; Tsuchiya A; Ishii T; Kuyama Y
    Thromb Res; 2007; 120(4):465-9. PubMed ID: 17257659
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society.
    Kuliczkowski W; Witkowski A; Watala C; Filipiak KJ; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Polonski L;
    Kardiol Pol; 2008 Apr; 66(4):470-6, 480-5. PubMed ID: 18473281
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiplatelet therapy and gastrointestinal complications].
    Hokimoto S; Ogawa H
    Nihon Shokakibyo Gakkai Zasshi; 2009 Nov; 106(11):1582-8. PubMed ID: 19893287
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic principles of prevention and rehabilitation in gastroenterology].
    Mörl M; Tuschhoff T
    Offentl Gesundheitswes; 1984 Mar; 46(3):113-7. PubMed ID: 6232477
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal side effects of tetracycline and its possible prevention by antifungal compounds.
    Mehrotra AN; Thomas Z; Goyal VP
    J Assoc Physicians India; 1970 Jul; 18(7):627-9. PubMed ID: 5473878
    [No Abstract]   [Full Text] [Related]  

  • 12. AGA seeks to reduce preventable GI health issues.
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):183. PubMed ID: 25011135
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical epidemiology and preventive medicine in gastroenterology].
    Zubirán S
    Rev Invest Clin; 1968; 20(1):109-16. PubMed ID: 5674139
    [No Abstract]   [Full Text] [Related]  

  • 14. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antiplatelet agents.
    Spectre G; Varon D
    Curr Opin Hematol; 2009 Sep; 16(5):365-70. PubMed ID: 19587588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA
    Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastroenterology in the elderly].
    Rodríguez Mañas L; Morales F; Francisco Parodi J; Pablo Marín P; Paixao CM
    Rev Gastroenterol Mex; 2006 Nov; 71 Suppl 2():35-46. PubMed ID: 17465189
    [No Abstract]   [Full Text] [Related]  

  • 18. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
    Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience in prevention of diseases of the organs of digestion and anti-recurrence therapy].
    Miasnikov NA; Brodovskiĭ VV
    Voen Med Zh; 1966 Apr; 4():77-9. PubMed ID: 5985910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gastroenterology; the struggle against intestinal diseases of parasitic origin].
    CASAL MA; BUQUET JA; COTELLA PJ
    Sem Med; 1957 Mar; 110(11):349-57. PubMed ID: 13454983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.